# The Ohio State University Wexner Medical Center account plan

> Ohio State Wexner Medical Center is central Ohio's academic medical center: seven hospitals, nearly 1,500 beds, $6.28 billion Health System revenue in FY2026.

## At a glance

The Ohio State University Wexner Medical Center is the academic medical center of The Ohio State University, a public university and component unit of the State of Ohio; its Ohio State Health System is governed by the university's Board of Trustees. The Health System runs seven hospitals, a network of ambulatory care locations and nearly 1,500 open inpatient beds, providing primary to quaternary care and serving as a tertiary and quaternary referral center for Ohio and the Midwest. In FY2025 (year to June 30, 2025) it treated about 61,200 inpatients and 1,803,000 outpatients. In FY2026 (year to June 30, 2026, unaudited) Health System sales and services rose 13.9% to $6.28 billion and the physician group Ohio State University Physicians, Inc. (OSUP) rose 8.0% to $1.30 billion, together $7,585 million, about 70% of university operating revenue (computed).

## Business units

- **University Hospital**: The flagship hospital, a Level I Trauma Center and central Ohio's only adult burn center and only adult solid organ transplant program, strong in transplantation, women and infants, digestive diseases and bariatric surgery. The new 26-story University Hospital ($1.79 billion, 820 private rooms, 234 intensive care beds) opened in February 2026 and drove patient activity and strong occupancy in FY2026.
- **Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (The James)**: The only freestanding cancer hospital in central Ohio and one of only 57 NCI-designated comprehensive cancer centers. The James Outpatient Care houses central Ohio's first Proton Therapy Center, with Nationwide Children's Hospital. It is led by CEO W. Kimryn Rathmell, former director of the National Cancer Institute.
- **Richard M. Ross Heart Hospital**: Comprehensive heart and vascular care, from open heart surgery and electrophysiology to vascular surgery, advanced heart failure and emergency cardiac care.
- **Ohio State Harding Hospital**: Inpatient and outpatient mental and behavioral health services for adolescents, adults and older adults.
- **Brain and Spine Hospital**: Dedicated units for stroke, neurotrauma, spinal cord injury and spine surgery, epilepsy, chronic pain, acute rehabilitation, neurosurgery and sleep medicine.
- **East Hospital**: Academic medicine in a community setting: orthopedics, general, vascular and plastic surgery, ENT, cardiovascular and pulmonary care, emergency medicine, addiction recovery and a wound-healing center.
- **Dodd Rehabilitation Hospital**: Inpatient rehabilitation for amputee, cancer, stroke, brain and spinal cord patients.
- **Ambulatory Services**: Primary care, sports medicine, orthopedics, mammography, imaging and wound care across Ohio, including Outpatient Care New Albany and Dublin; Outpatient Care Powell ($183 million) is set to open in August 2026.
- **Specialty outpatient pharmacy** ($577.4 million of FY2025 Health System operating revenue): Specialty oral and self-administered drugs for cancer and non-cancer patients, up from $460.9 million in FY2024; volumes kept growing in FY2026 and contributed to the operating margin.
- **Ohio State University Physicians, Inc. (OSUP)** ($1,303.9 million FY2026 revenue): The central practice group for physician faculty of the College of Medicine. Revenue rose 8.0% in FY2026 on primary care and community outreach, specialty growth, regional outpatient clinics, extended hours and community anesthesia providers, while expenses rose 11.1% on provider costs.

## Strategic priorities

- **Ramping up the new University Hospital**: The 26-story tower opened in February 2026; the FY2027 plan expects inpatient discharges to grow 7.0% with its added bed capacity, and the Health System is focused on throughput, workforce retention and optimizing the new hospital.
- **Outpatient and specialty growth**: The FY2027 plan targets outpatient activity +5.1% (imaging, rehab, surgery, drug infusions) and surgery +3.9%, with the cancer program, new ambulatory services and surgical specialties leading growth; Health System sales and services are planned at $6.66 billion, up 7.1%.
- **Workforce retention and recruitment**: The FY2027 plan adds about 1,300 FTEs with 3.0% merit plus 1.5% market salary increases; FY2026 had planned 5.5% increases for the Health System and OSUP.
- **Margin discipline**: The Health System budgets a $213.8 million margin for FY2027 (3.2% total margin, 8.9% EBIDA margin), relying on revenue enhancement and performance improvement initiatives to offset inflation in labor, supplies, drugs and services.
- **Cancer care access across Ohio**: The James CEO is prioritising awareness of early-onset cancer and research-based care in underserved rural, Appalachian and urban areas, adding the community as a fourth leg of the mission.
- **Education for Citizenship 2035**: The university's 10-year plan funds the hospital tower, research expansion toward $2 billion, 100 new AI faculty and tuition-free pathways.

## Latest results

In FY2026 (year to June 30, 2026, unaudited), Ohio State Health System sales and services rose $767 million (13.9%) to $6,280.7 million and OSU Physicians rose $96 million (8.0%) to $1,303.9 million. Growth came from higher inpatient acuity, outpatient services, and infusion, radiation, imaging, cardiac and transplant volumes that beat both budget and prior year, plus the new University Hospital and specialty pharmacy. Health System expenses rose 9.5% to $5,441.3 million. The university's operating loss narrowed to $567.1 million from $690.0 million, and total debt fell to $4,250 million after a $561 million refunding. For FY2027 the plan sets Health System sales and services at $6.66 billion (+7.1%) and a $213.8 million margin.

## Investments and deals

- **New University Hospital**: A $1.79 billion, 26-story, 1.9 million square foot tower with 820 private rooms and 234 intensive care beds, the largest facilities project in the university's history; opened in February 2026, with $46.9 million remaining in the capital plan.
- **Suburban outpatient program**: Outpatient Care Powell ($183 million, opening August 2026) follows New Albany and Dublin; the capital plan also lists Outpatient Care West Campus ($10.4 million).
- **Interim Capital Investment Plan through FY2031**: $1.37 billion across the university and the Wexner Medical Center ($754.0 million prior commitments, $613.4 million new), including a magnetic resonance linear accelerator ($10.3 million), an OSU East OR renovation ($7.5 million), the James Cellular Therapy Lab ($6.8 million) and the Doan Hall roof ($14.0 million); a $400 million bond issuance is assumed in FY2027.
- **Health System capital additions**: The Health System accounted for $647 million of the university's $1.06 billion of capital additions in FY2025, covering facilities, infrastructure, land and equipment.

## Challenges and risks

- **Rising labor, supply and drug costs**: FY2025 Health System operating expenses rose $577.1 million (12.8%), including supplies and drugs +$299.6 million (19.9%) and purchased services +$119.6 million (18.6%); the FY2027 plan expects operating expenses +9.6% and drugs +7.8%.
- **Reimbursement pressure**: The FY2027 plan assumes government base rates of only +1.0%, reductions from the 340B program and HCAP state directed payments, and healthcare reform impacts on reimbursement.
- **Thin budgeted margin**: The FY2027 budgeted total margin is 3.2%, down from a FY2026 forecast of $367.6 million to $213.8 million, while it must fund $595.0 million of faculty support.
- **Heavy capital needs**: Net capital uses of $341.3 million in FY2027 reduce the Health System's $446.9 million operating surplus to $105.6 million after capital.
- **Receivables and legal costs**: Health System patient care receivables rose $173 million in FY2026, and the university booked an $80 million accrual for legal settlements.

## What leadership says

> "This needs to be done in an ecosystem or laboratory, and our laboratory is Ohio" — W. Kimryn Rathmell, CEO of OSUCCC - James, Company-site interview on her vision for The James, May 27, 2025

> "It's a substantial enough gift that it can become pilot or seed money for projects that take us in new and exciting directions." — W. Kimryn Rathmell, CEO of OSUCCC - James, On the $10 million Block and Schottenstein endowed chair, company-site interview, May 27, 2025

> "Ultimately, it will be a world where people don't fear cancer the way we do today." — W. Kimryn Rathmell, CEO of OSUCCC - James, On a cancer-free world, company-site interview, May 27, 2025


## Where a supplier can help

- **Operating the new hospital tower**: With the tower open since February 2026 and throughput and optimization of the new hospital a stated priority, suppliers of patient-flow, bed management, facilities and clinical equipment services have a live need.
- **Workforce retention**: About 1,300 planned FTE additions and retention as a stated focus open doors for recruiting, staffing, scheduling and employee-experience offers.
- **Drug and supply cost control**: Supplies and drugs rose 19.9% in FY2025 and drugs are budgeted +7.8% in FY2027, so procurement, pharmacy and infusion cost-management solutions tie directly to the margin target.
- **Outpatient and suburban expansion**: Outpatient Care Powell opening and the outpatient growth target create demand for ambulatory equipment, imaging, IT and building services.
- **Cancer outreach and research**: The James CEO's focus on early-onset cancer and community outreach across rural and urban Ohio, plus seed money from the endowed chair, suits screening, outreach and clinical-trial partners.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [The Ohio State University Financial Report 2025 (fiscal year ended June 30, 2025)](https://busfin.osu.edu/sites/default/files/documents/Ohio_State_Financial_Report_2025-accessible_0.pdf)

Annual report

- The Ohio State University Wexner Medical Center is part of The Ohio State University, a public university and a component unit of the State of Ohio; its Ohio State Health System is governed by the university's Board of Trustees and comprises seven hospitals and a network of ambulatory care locations, with nearly 1,500 open inpatient beds.
- FY2025 (year ended June 30, 2025): Ohio State Health System operating revenues increased $625 million to $5.51 billion, driven by growth in outpatient volumes; university total operating revenues were $8.52 billion (up $805 million) and operating expenses $9.39 billion.
- Activity: about 61,200 inpatients and 1,803,000 outpatients in FY2025; admissions up 1.0%, average length of stay improved 2.9%, surgeries up 3.2%, outpatient volumes up 8.0% (infusion and procedural services).
- Payor mix of the $4.77 billion net patient service revenue: Medicare $1.43 billion, Anthem $929 million, United Healthcare $670 million, Medicaid $666 million, MMO $280 million, Aetna $246 million.
- Cost pressure: Health System operating expenses rose $577.1 million (12.8%): supplies and drugs +$299.6 million (19.9%), salaries and benefits +$140.7 million (7.5%), purchased services +$119.6 million (18.6%, incl. IT maintenance and utilities).
- Capital: Health System capital additions of $647 million out of $1.06 billion for the university; the $1.79 billion, 26-story new University Hospital (820 private rooms, 234 intensive care beds) was about 92% complete at June 30, 2025; Outpatient Care Powell ($183 million) set to open in August 2026.
- Growth lines: specialty outpatient pharmacy contributed $577.4 million of operating revenue (vs $460.9 million in FY2024); OSU Physicians, Inc. revenues rose $93 million to $1.19 billion.
- FY2026 plan: Health System operating surplus of $430.5 million excluding capital, a loss of $96.9 million after $527.4 million of net capital uses, driven by completing the hospital tower; Health System and OSUP salary increases of 5.5% for retention and recruitment.
- The university's credit rating was upgraded to 'AA+' by S&P; the long-term investment pool returned 11.81% and reached $8.62 billion.

### [Fiscal Year 2026 Financial Report - June 30, 2026 (unaudited)](https://busfin.osu.edu/sites/default/files/documents/interim_financial_report_2026_06.pdf)

Interim report · 2026-09-04

- Unaudited year-end report for fiscal 2026 (twelve months to June 30, 2026), published by Ohio State's Office of Business and Finance.
- Sales and services of the Ohio State Health System rose $767 million (13.9%) to $6.28 billion; OSU Physicians rose $96 million (8.0%) to $1.30 billion; together healthcare revenues rose $863 million to $7,585 million.
- Drivers: higher inpatient acuity, outpatient growth; infusion, radiation, imaging, cardiac volumes and transplants beat budget and prior year; the new University Hospital, opened in February 2026, drove patient activity and strong occupancy; specialty outpatient pharmacy volumes grew.
- University operating revenues rose $901 million (9.0%) to $10.88 billion; operating loss narrowed to $567 million from $690 million as healthcare revenue outpaced healthcare expenses.
- Health System and OSU Physicians expenses (excluding pension and OPEB, including depreciation and interest) rose $644 million to $6,737 million; focus on throughput, workforce retention and optimizing the new hospital.
- Net position rose $1,844 million; long-term investment pool returned 16.03% to $9,744 million.
- Health System patient care receivables rose $173 million; an $80 million accrual for legal settlements was booked; total debt fell to $4,250 million after a $561 million refunding (Series 2026A).
- State grants fell $35 million while federal grants rose $21 million and private grants $48 million.

### [The Ohio State University FY 2027 Financial Plan](https://busfin.osu.edu/sites/default/files/documents/FY27%20FINANCIAL%20PLAN%20-%20FINAL_0.pdf)

Report · 2026-05-21

- Ohio State's FY2027 Financial Plan (budget, May 2026) covering the university, the Ohio State Health System and OSU Physicians, Inc., aligned with the Education for Citizenship 2035 strategic plan.
- Health System: sales and services planned at $6.66 billion in FY2027, up 7.1% from a FY2026 forecast of $6.22 billion; operating surplus $446.9 million excluding capital, $105.6 million after $341.3 million of net capital uses.
- Budgeted Health System margin $213.8 million: total margin 3.2%, EBIDA margin 8.9%; includes $595.0 million of support for faculty clinical, academic and research investments.
- Volume plan: inpatient discharges +7.0% with the new University Hospital's bed capacity, outpatient +5.1%, surgery +3.9%; cancer program, new ambulatory services and surgical specialties lead growth.
- Pricing: managed care contracts negotiated through FY2027 (some into FY2028) at about 4.0% average rate growth; government payor base rates +1.0%; reductions expected from the 340B program and HCAP state directed payments; healthcare reform impacts assumed.
- Costs: operating expenses +9.6%, about 1,300 FTE growth, 3.0% merit plus 1.5% market increases, benefits +5.6%, drugs +7.8% (infusions, cancer drugs), services +$45 million (IT, full year of the new hospital, franchise fees).
- OSU Physicians: total sources $1.48 billion (+13.3%), net patient revenue +7.3%, $232.0 million of Medical Center Investment transfers, operating surplus $4.5 million.
- Capital: $1.37 billion Interim Capital Investment Plan through FY2031 ($754.0 million prior commitments, $613.4 million new), including Outpatient Care Powell and the inpatient hospital; an assumed $400 million bond issuance in FY2027.

### [New James CEO W. Kimryn Rathmell on her leadership approach and vision](https://health.osu.edu/health/cancer/james-cancer-center-new-ceo)

Executive talk · W. Kimryn Rathmell, CEO of OSUCCC - James (The James Cancer Hospital and Solove Research Institute) · 2025-05-27

- Company-site profile and interview of W. Kimryn Rathmell, MD, PhD, new CEO of The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), published May 27, 2025.
- She previously directed the National Cancer Institute (December 2023 to January 2025) and chaired medicine at Vanderbilt; she oversees both the clinical and research sides of Ohio State's cancer program.
- Priorities: raising awareness of early-onset cancer and access to high-quality cancer care for all, taking research-based care to underserved rural and urban areas.
- Ohio as a test bed: "our laboratory is Ohio", covering rural America, Appalachia, urban centers and immigrant communities.
- Adds the community as a fourth leg to patient care, research and education, a "quadripartite" mission she calls a "secret sauce".
- Funding: holds the $10 million Jeri B. Block and Robert H. Schottenstein Distinguished Chair in Cancer, the largest endowed chair at Ohio State, to be used as pilot or seed money; cites Pelotonia community fundraising.
- Leadership style self-described as "visionary but grounded"; goal of a cancer-free world built on prevention, early detection and better treatment.

## Questions about The Ohio State University Wexner Medical Center

### What is The Ohio State University Wexner Medical Center?

It is the academic medical center of The Ohio State University. Its Ohio State Health System runs seven hospitals, including University Hospital and The James cancer hospital, plus ambulatory care locations, with nearly 1,500 open inpatient beds.

### What is the Wexner Medical Center's revenue?

In FY2026 (year to June 30, 2026, unaudited) Ohio State Health System sales and services were $6.28 billion, up 13.9%, and OSU Physicians $1.30 billion; together $7,585 million.

### What is the new University Hospital?

A $1.79 billion, 26-story tower with 820 private rooms and 234 intensive care beds that opened in February 2026 and is expected to drive 7.0% inpatient discharge growth in FY2027.

### What are its priorities for FY2027?

Growing Health System sales and services 7.1% to $6.66 billion, ramping up the new hospital, outpatient and cancer program growth, adding about 1,300 FTEs, and holding a 3.2% total margin.

### Who leads The James cancer hospital?

W. Kimryn Rathmell, MD, PhD, former director of the National Cancer Institute, is CEO of OSUCCC - James.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
